News

Thiacloprid now Effectively Banned in the EU

Aramco Exercises Greenshoe Option

New Study Relativizes Talc-Cancer Ties

Galen Takes POA Pharma

Clariant Technology for China Ethanol JV

ISPE Appoints Tim Howard as Acting CEO and President

Caldic Buys Malaysia’s DCM Asia

Almirall Takes Option on Bioniz Therapeutics

Ineos Styrolution to Build ABS plant in China

Astellas Acquires Xyphos Biosciences

Chemours Sells Methylamines to Belle Chemical

Avantium to Build FDCA Plant at Delfzijl

US Supreme Court Declines Sackler Case

ChemChina and Sinochem Merge Agrochemicals

EU Said Moving Toward Plastic Waste Tax

Elkem Takes China’s Polysil

SABIC Liquidates Subsidiaries

BASF Ultrafiltration Membranes now with DuPont

J&J Wins one Lawsuit, New Cases Loom

DKSH Takes Australia’s Axieo

Ascend Finalizes $175 Million ADN Project in Alabama

LyondellBasell and Sinopec in JV for PO and SM

Lone Star Takes BASF Construction Chemicals

US to Allow Drug Reimports from Canada

Court Hears DuPont-Chemours Dispute Arguments

Clariant to Sell Masterbatch Arms to PolyOne

Novozymes and Green Plains Partner on Proteins

Brenntag Boosts UK Presence with Tan Buy

BASF Starts Phase 2 of Shanghai Antioxidants Plant

Bayer to Appeal Hardeman Roundup Verdict

Arkema Buys Danish Adhesives Firm

DuPont Merges Nutrition Arm into IFF

Archroma: Heike van de Kerkhof to Succeed Alexander Wessels as CEO

Markus Kimpel Appointed as CFO of Romaco Group

Azelis Enters Latin America with Megafarma

Azelis is entering the Latin American market following an agreement to buy Megafarma, a Mexican specialty distributor for the pharma, food and veterinary industries. Financial terms of the deal, which is expected to close within the next month, were not disclosed.